✦ LIBER ✦

Efficacy and Safety of Tapentadol Extended Release Compared with Oxycodone Controlled Release for the Management of Moderate to Severe Chronic Pain Related to Osteoarthritis of the Knee

✍ Scribed by Marc Afilalo, Dr Mila S. Etropolski, Brigitte Kuperwasser, Kathy Kelly, Akiko Okamoto, Ilse Van Hove, Achim Steup, Bernd Lange, Christine Rauschkolb, Juergen Haeussler

Book ID: 119930832
Publisher: Springer International Publishing AG
Year: 2010
Tongue: English
Weight: 202 KB
Volume: 30
Category: Article
ISSN: 1179-1918
DOI: 10.2165/11533440-000000000-00000

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

328 EFFICACY AND SAFETY OF TAPENTADOL EX

328 EFFICACY AND SAFETY OF TAPENTADOL EXTENDED RELEASE VERSUS OXYCODONE CONTROLLED RELEASE IN OPIOID-NAIVE AND OPIOID-EXPERIENCED PATIENTS WITH CHRONIC PAIN ASSOCIATED WITH OSTEOARTHRITIS OF THE KNEE

✍ M. Etropolski; B. Lange; B. Kuperwasser; K. Kelly; A. Okamoto; A. Steup; I. Van 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 191 KB

Long-Term Safety of Remoxy® (Extended-Re

Long-Term Safety of Remoxy® (Extended-Release Oxycodone) in Patients with Moderate to Severe Chronic Osteoarthritis or Low Back Pain

✍ Nadav Friedmann; Vicki Klutzaritz; Lynn Webster 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 206 KB

Budget Impact Analysis of Tapentadol Ext

Budget Impact Analysis of Tapentadol Extended Release for the Treatment of Moderate to Severe Chronic Noncancer Pain

✍ Merchant, Sanjay; Noe, Les L.; Howe, Andrew; Duff, Steve; Gricar, Joe; Ogden, Kr 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 486 KB

(224) Tapentadol immediate release compa

(224) Tapentadol immediate release compared with oxycodone immediate release for the relief of moderate-to-severe pain in patients with end stage joint disease

✍ M. Afilalo; C. Oh; A. Okamoto; I. Van Hove; J. Stegmann; D. Upmalis 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 38 KB

Ready Conversion of Patients with Well-C

Ready Conversion of Patients with Well-Controlled, Moderate to Severe, Chronic Malignant Tumor–related Pain on Other Opioids to Tapentadol Extended Release

✍ Imanaka, Keiichiro; Tominaga, Yushin; Etropolski, Mila; Ohashi, Hiroki; Hirose, 📂 Article 📅 2014 🏛 Springer International Publishing AG 🌐 English ⚖ 390 KB

Sustained Safety and Efficacy of Once-Da

Sustained Safety and Efficacy of Once-Daily Hydromorphone Extended-Release (OROS® hydromorphone ER) Compared with Twice-Daily Oxycodone Controlled-Release Over 52 Weeks in Patients with Moderate to Severe Chronic Noncancer Pain

✍ Ute Richarz; Sandra Waechter; Rainer Sabatowski; Leszek Szczepanski; Heinrich Bi 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 403 KB